Mineralocorticoid receptor antagonism in diabetes reduces albuminuria by preserving the glomerular endothelial glycocalyx.
Crompton M, Ferguson JK, Ramnath RD, Onions KL, Ogier AS, Gamez M, Down CJ, Skinner L, Wong KH, Dixon LK, Sutak J, Harper SJ, Pontrelli P, Gesualdo L, Heerspink HL, Toto RD, Welsh GI, Foster RR, Satchell SC, Butler MJ.
Crompton M, et al. Among authors: gamez m.
JCI Insight. 2023 Mar 8;8(5):e154164. doi: 10.1172/jci.insight.154164.
JCI Insight. 2023.
PMID: 36749631
Free PMC article.
Clinical Trial.